Suicidal and self‐injurious behavior following adalimumab reference‐to‐generic biosimilar switch

Authors :: Sotiris Posporelis
Mena Farag
Ester Coutinho
Catherine Ward
Thomas A Pollak
Source :: Psychiatry and Clinical Neurosciences. 76:59-62
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Psychotherapist
business.industry
General Neuroscience
MEDLINE
Biosimilar
General Medicine
Psychiatry and Mental health
Neurology
Adalimumab
Medicine
Neurology (clinical)
business
Self-injurious behaviour
medicine.drug

Full Text Access

Tools